The instant invention provides novel cholesterol absorption inhibitors of Formula I and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
本发明提供了I式
胆固醇吸收
抑制剂及其药学上可接受的盐和酯的新颖化合物。这些化合物可用于降低血浆
胆固醇水平,特别是低密度脂蛋白
胆固醇,并用于治疗和预防动脉硬化和动脉粥样硬化疾病事件。